Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
KENYON LAWRENCE A
Chief Financial Officer at Outlook Therapeutics. Filing since 22 Dec 2017.
CIK 0001230484
Company
Date
Role
Action
Shares
Amount
Of holding
OTLK
Outlook Therapeutics, Inc.
14 Aug 2026
Chief Financial Officer
Bought
101,010
no price
×17
OTLK
Outlook Therapeutics, Inc.
26 Sep 2024
Chief Financial Officer
Bought
5,000
$28.45K
529%
OTLK
Outlook Therapeutics, Inc.
20 Apr 2021
CEO, Pres, CFO, Treas & Secy
Bought
10,000
$18.30K
112%
OTLK
Outlook Therapeutics, Inc.
18 Sep 2019
CEO, Pres, CFO, Treas & Secy
Sold, plan not stated
1,350
$2.30K
1.6%
OTLK
Outlook Therapeutics, Inc.
7 Feb 2019
CEO, Pres, CFO, Treas & Secy
Bought
25,000
$22.38K
43.7%
OTLK
Outlook Therapeutics, Inc.
18 Sep 2018
CEO, Pres, CFO, Treas & Secy
Sold, plan not stated
10,100
$8.81K
15.0%
OTLK
Outlook Therapeutics, Inc.
22 Dec 2017
CFO and Secretary
Sold, plan not stated
26,165
$29.57K
28.0%
7 decisions on file.
